Partnership with Daiwa Pharmaceutical on dietary guidelines in cancer

The University of Luxembourg and Daiwa Pharmaceutical, a Japanese leading supplier of functional foods, have entered a strategic partnership, along with the Centre Hospitalier Emile Mayrisch and the Luxembourg Institute of Health, with the aim to study dietary supplements for cancer patients and to identify the underlying mechanisms between gut bacteria (microbiome), its derived metabolites and patient immune cells.
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.